glp 1 gip receptor agonist Schematic illustration of monoagonists, dual agonists and triple Mechanisms of action of GLP-1
Description
They are typically for individuals with commercial insurance
The risk is lower when combined with metformin alone
Kettmann, U., Humbel, B
doi: 10.1016/S2213-2600(19)30198-5, 2
(2011) Effects of short-term therapy with glibenclamide and repaglinide on incretin hormones and oxidative damage associated with postprandial hyperglycaemia in people with type 2 diabetes mellitus
